Feener Edward P.

CIK 00016910901 companySALISBURY, WILTSHIRE, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001691090

Recent Transactions

50 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-05-20$11.76/sh−8,088→ 72,858 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-05-17−7,292→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-05-17−1,774→ 14,190 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-05-17−2,431→ 14,583 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-05-17−7,292→ 14,583 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-05-17+18,789→ 80,946 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-20$14.04/sh−19,591→ 62,457 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-20$14.11/sh−8,397→ 82,048 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-20$14.72/sh−300→ 62,157 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-02-17−1,774→ 15,964 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-17+18,788→ 90,445 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-02-17−7,292→ 21,875 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-02-17−2,430→ 17,014 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-02-17−7,292→ 7,292 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-14$15.01/sh−28,171→ 71,657 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-02-11+60,000→ 99,828 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-02-11+29,167→ 29,167 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-01-11$13.03/sh−22,679→ 39,828 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-01-09$13.00/sh−100→ 62,507 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-01-08$13.01/sh−17,221→ 62,607 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-11-20$8.23/sh−4,958→ 79,828 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-11-17−1,774→ 17,738 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-11-17−2,431→ 19,444 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Unit
2023-11-17−7,292→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-11-17+11,497→ 84,786 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-08-18$10.73/sh−4,976→ 73,289 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-08-17−1,773→ 19,512 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Unit
2023-08-17−7,291→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-08-17+11,494→ 78,265 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-08-17−2,430→ 21,875 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-05-18$10.14/sh−1,786→ 66,771 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-05-17−2,431→ 24,305 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-05-17+4,205→ 68,557 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-05-17−1,774→ 21,285 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Restricted Stock Unit
2023-02-17−2,430→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-02-17+4,204→ 66,580 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2023-02-17$7.66/sh−2,228→ 64,352 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-02-17−2,430→ 26,736 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-02-17−1,774→ 23,059 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2023-01-11+29,166→ 29,166 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-11-18$5.44/sh−530→ 62,376 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-11-17+1,774→ 62,906 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2022-11-17−1,774→ 24,833 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-08-17$14.96/sh−532→ 61,132 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2022-08-17−1,773→ 26,607 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-08-17+1,773→ 61,664 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Employee Stock Option (Right to Buy)
2022-05-17+18,920→ 18,920 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Units
2022-05-17+28,380→ 28,380 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Employee Stock Option (right to buy)
2022-01-07−33,800→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2022-01-07$8.21/sh+23,857→ 59,891 total

Companies

KalVista Pharmaceuticals, Inc.
Chief Scientific Officer
$KALV

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. BUILDING 227, TETRICUS SCIENCE PARK

SALISBURY, WILTSHIRE, X0, SP4 0JQ

View on SEC.gov